We did not observe any frontal-to-temporal lobe transition during recurrence in a reference cohort of IDH-mutant gliomas (including 56 non-PNC astrocytomas and 48 oligodendrogliomas). This evidence concerns the gene IDH2 and central nervous system cancer.